The conflicting safety signal One real-world evidence study found that patients receiving GLP-1 receptor agonists had higher risks of certain autoimmune conditions, including ulcerative colitis, rheumatoid arthritis, autoimmune thyroiditis, ankylosing spondylitis, and psoriasis, compared to those on DPP-4 inhibitors
Compounded formulations are prepared by licensed pharmacies using pharmaceutical-grade active ingredients under quality standards, but without that branded trial portfolio
[1] However, several indirect factors related to semaglutide use may theoretically influence UTI risk in certain circumstances
Minimising alcohol consumption, particularly around injection days or dose increases, is also advisable
Diarrhea is Accompanied by Severe Abdominal Pain or Cramping : These could indicate a more serious gastrointestinal issue